ImmuPharma PLC logo

ImmuPharma PLC

£ 0.06 (-1.17%) Aug 18
P/E:
At Loss
P/B:
3.95
Market Cap:
£ 19.41M ($ 22.94M)
Enterprise V:
£ 17.82M ($ 21.05M)
Volume:
2.06M
Avg Vol (2M):
1.29M
Also Trade In:
Volume:
2.06M
Market Cap £:
19.41M
Market Cap $:
22.94M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.29M
Enterprise Value £:
17.82M
Enterprise Value $:
21.05M
PB Ratio:
3.95
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

ImmuPharma PLC
NAICS : 325412
One Bartholomew Close, London, GBR, EC1A 7BL
Description
ImmuPharma PLC is a drug discovery and development company. Its pipeline includes novel peptide-based therapeutics within four therapy areas: Autoimmunity & Inflammation, Anti-Infectives, Metabolism, and Cancer. Its lead drug candidate is Lupuzor, which is a treatment for lupus and life-threatening autoimmune disease.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 1599
Equity-to-Asset 0.74
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.33
Distress
Grey
Safe
Beneish M-Score -5.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 70.42
9-Day RSI 59.27
14-Day RSI 54.55
6-1 Month Momentum % -13.81
12-1 Month Momentum % -20.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.11
Quick Ratio 2.11
Cash Ratio 1.01
Days Sales Outstanding 854.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.9

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -4335.29
Net Margin % -6868.91
ROE % -126.53
ROA % -102.19
ROIC % -134.64
ROC (Joel Greenblatt) % -1178.08
ROCE % -136.46

Financials (Next Earnings Date:2022-09-29 Est.)

LSE:IMM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 0.119
EPS (TTM) (£) -0.033
Beta 1.54
Volatility % 50.72
14-Day RSI 54.55
14-Day ATR (£) 0.00511
20-Day SMA (£) 0.057845
12-1 Month Momentum % -20.61
52-Week Range (£) 0.048 - 0.095
Shares Outstanding (Mil) 327.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ImmuPharma PLC Filings

Document Form Filing Date
No Filing Data